Bay Street News

T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference

LEXINGTON, Mass., July 30, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming virtual Canaccord Genuity Annual Growth Conference.
Management is scheduled to present Thursday, August 13, 2020 at 9:30am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Company’s website at www.t2biosystems.comMedia Contact:
Gina Kent, Vault Communications
gkent@vaultcommunications.com  
610-455-2763
Investor Contact:
Philip Trip Taylor, Gilmartin Group
philip@gilmartinIR.com
415-937-5406


Bay Street News